A U.S. cannabis company has made a bid to acquire Aurora Cannabis Inc., based in Edmonton. Aurora has set up a special committee to review the unsolicited offer from Curaleaf Holdings Inc., which aims to purchase all of Aurora’s shares. If successful, this acquisition would form a combined cannabis entity operating in 17 countries worldwide.
Curaleaf, headquartered in Stamford, Connecticut, and listed on the Toronto Stock Exchange, disclosed its intentions publicly after unsuccessful private negotiations with Aurora’s leadership. Despite sending formal letters of intent on June 23 and a follow-up on July 7, Aurora’s board has not engaged in meaningful discussions, according to Curaleaf CEO Boris Jordan.
The proposed deal includes paying Aurora shareholders $4 US per share, in addition to $0.75 US cash for each Aurora share. Aurora confirmed receiving the letters but disputed Curaleaf’s claim that it rejected the offer outright. The Canadian company’s independent director recently communicated with Curaleaf’s CEO, indicating a willingness to explore potential discussions moving forward.
Aurora plans to establish a special committee of independent directors to assess the proposal’s implications for stakeholders. While expressing interest in Curaleaf’s bid, analysts believe the offer undervalues Aurora’s long-term prospects given its market leadership in medical cannabis and strong business fundamentals.
Curaleaf believes merging the two companies would create significant value by leveraging its global distribution network with Aurora’s established international medical cannabis operations. The combined revenue of both companies exceeded $1.5 billion US over the past year, with anticipated cost synergies of $40 million US annually from the potential acquisition.
Jordan emphasized that the merger would benefit shareholders by providing access to a more diversified global platform and exposure to favorable U.S. regulatory trends. Both companies are optimistic about the potential synergies and growth opportunities arising from the proposed deal.